Next-Generation Sequencing (NGS)-assisted SELEX service
Info Center
Home » aptamer screening service » Next-Generation Sequencing (NGS)-assisted SELEX service

Next-Generation Sequencing (NGS)-assisted SELEX service

Date:2026-01-07

Traditional SELEX (Systematic Evolution of Ligands by EXponential enrichment) is a method to select high-affinity, specific nucleic acid aptamers from a vast random library (10¹³-10¹⁵ sequences). The bottleneck has always been the final cloning and Sanger sequencing of only a few dozen candidates, which often misses rare, high-performance aptamers.

NGS-assisted SELEX integrates Next-Generation Sequencing at multiple rounds of the SELEX process. This provides a massive, data-rich view of the entire evolutionary landscape, enabling intelligent selection and identification of the best aptamers.


Typical Workflow of an NGS-Assisted SELEX Service

A professional service provider will manage this entire pipeline:

  1. Project Design & Library Synthesis: Collaboration to define target (protein, small molecule, cell), counter-selection requirements, and library design (random region length, fixed primers for NGS).

  2. Parallel SELEX Execution: Performing the iterative selection process (binding, partitioning, amplification) across multiple rounds (usually 8-12).

  3. Key NGS Integration Points:

    • Initial Library Analysis: Sequencing the naive library to confirm diversity and complexity.

    • Monitoring Rounds (e.g., Rounds 3, 6, 9): Taking small samples from intermediate rounds for NGS. This is the critical advantage. It tracks:

      • Sequence Enrichment: Which families are becoming more abundant.

      • Diversity Collapse: When to stop selection before losing good candidates.

      • Informed Decision-Making: Data guides adjustments in selection stringency for subsequent rounds.

  4. Final Round Deep Sequencing: Comprehensive NGS of the final enriched pool (millions of reads).

  5. Bioinformatics & Aptamer Identification: This is where the real power lies. The service analyzes the NGS data to:

    • Cluster sequences into families based on similarity.

    • Track enrichment kinetics of each family/sequence across rounds (the most powerful predictor of affinity).

    • Perform in silico analysis to predict secondary structures and identify conserved motifs.

    • Generate a ranked list of candidate aptamers (e.g., top 20-50), not just based on final abundance, but on enrichment profiles.

  6. Validation Support: The service typically delivers the candidate sequences, along with synthesis and initial validation (e.g., SPR, ELISA, flow cytometry) of the top hits to confirm binding affinity & specificity.


Key Advantages Over Traditional SELEX

Feature Traditional SELEX NGS-Assisted SELEX
Throughput ~100 sequences analyzed Millions of sequences analyzed
Selection Insight Blind process, guided by crude binding assays Data-driven, visible enrichment dynamics
Candidate ID Based only on final round abundance Based on enrichment kinetics & clustering
Discovery of Rare Aptamers Unlikely, biased toward most abundant Highly probable, identifies rare high-affinity sequences
Process Control Limited; stop based on guesswork Precise; stop when diversity collapses or enrichment plateaus
Structural Motifs Hard to identify Easy to find conserved motifs across families
Time to Candidate Can be longer due to blind rounds Often shorter due to informed rounds and in silico ranking

What You Get from a Service Provider (Deliverables)

  1. Aptamer Candidates: A list of 20-50 validated sequences with their predicted structures and enrichment data.

  2. Comprehensive Data Report: NGS statistics, enrichment plots, cluster analysis, and motif identification.

  3. Binding Data: Affinity (Kd) and specificity data for the lead aptamers.

  4. Recommendations: For truncation, minimization, and modification of lead aptamers for stability/application.


Applications & Who Uses This Service

  • Therapeutic Aptamer Discovery: For targets where antibody development is difficult.

  • Diagnostic Sensor Development: Creating aptamers as capture/detection elements for point-of-care devices.

  • Agri-Biotech & Food Safety: Detection of toxins, pathogens, or contaminants.

  • Basic Research: Studying protein-ligand interactions or developing chemical probes.

  • Users: Biotech/pharma companies, academic labs without NGS/bioinformatics infrastructure, diagnostic developers.


Considerations When Choosing a Provider

  • Experience with Your Target Type: (soluble protein, membrane protein, whole cell, small molecule).

  • Bioinformatics Capability: This is crucial. Ask about their pipeline for enrichment analysis and clustering.

  • NGS Platform & Depth: Adequate sequencing depth (millions of reads per sample) is essential.

  • Validation Methods: How do they confirm binding (SPR, BLI, etc.)?

  • Project Flexibility: Can they incorporate negative/counter-selection steps for specificity?

Conclusion

NGS-assisted SELEX is now the gold standard for aptamer discovery. By transforming SELEX from a “black box” selection into a data-rich, observable evolutionary process, it dramatically increases the success rate, speed, and quality of aptamer generation. Outsourcing this service provides access to expert teams and sophisticated infrastructure, making high-performance aptamer discovery accessible without needing in-house NGS and bioinformatics expertise.

Would you like help identifying key providers or understanding specific parts of the bioinformatics analysis in more depth?